|Bid||38.72 x 800|
|Ask||38.95 x 1800|
|Day's Range||36.16 - 38.96|
|52 Week Range||2.91 - 66.99|
|Beta (5Y Monthly)||2.61|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||55.39|
For the past 41 years, through the dot-com bubble, Great Recession, and now, coronavirus crash, the broad-based S&P 500 has averaged an annual total return, including dividends, of more than 10%. Put another way, investors in S&P 500 tracking indexes are doubling their money about every seven years, inclusive of reinvestment. There are always bargains to be found, at least according to Wall Street.
Investors looking for stocks with explosive growth potential sometimes seek out companies in sectors like biotech, where the outcomes can be almost binary. Enough failures, and such companies' stock prices can go to zero.
Arcady Sosinov, Co-Founder & CEO of FreeWire, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss ultrafast charging for electric vehicles and challenges in the EV space.